HomeAll ContractsContract
XPRSARS-COV2-10 COVID TESTS SWAB/M-100 SWABS FOR TESTS QUOTE: 0020057890
Vendor
Total Committed
$735K
Product or Service Description
In Vitro Diagnostic Substances, Reagents, Test Kits and Sets
Total Potential Value
$735K
Contracting Agency
Effective Date
Sept. 25, 2020
Funding Department
USCG FINANCE CENTER
Type
Firm fixed price
Solicitation Procedure
Simplified acquisition
Extent Competed
Not competed under sap
Reason
Sap Non Competition (Far 13)

Recent Contract Actions

Contracts can have multiple “contract actions”: This is how agencies spend money for a specific purpose, adjust the amount committed or change the contract in a way that doesn’t affect the amount. That last scenario is usually indicated by a $0 action. If there is a contract action for a negative amount, it generally means the contract was adjusted or canceled.

Vendor Description Signed Reason for Change Amount Committed
CEPHEID XPRSARS-COV2-10 COVID TESTS SWAB/M-100 SWABS FOR TESTS QUOTE: 0020057890 March 18, 2021 Other Administrative Action $0
CEPHEID XPRSARS-COV2-10 COVID TESTS SWAB/M-100 SWABS FOR TESTS QUOTE: 0020057890 Oct. 20, 2020 Supplemental Agreement For Work Within Scope $0
CEPHEID XPRSARS-COV2-10 COVID TESTS SWAB/M-100 SWABS FOR TESTS QUOTE: 0020057890 Sept. 25, 2020 $735,490
About this data
This data comes from the Federal Procurement Data System, which includes all contracts worth $10,000 or more. We look at all contracts that are tagged with the procurement code for COVID-19 or otherwise started in 2020 and contain “COVID-19” in the description. Department of Defense contracting data is subject to a 90-day delay before it appears in the data.
Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print RSS Search Search Twitter WhatsApp
Current site Current page